
Sign up to save your podcasts
Or


Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.
By Colabra4.8
273273 ratings
Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.

32,245 Listeners

6,836 Listeners

30,726 Listeners

43,506 Listeners

9,242 Listeners

4,011 Listeners

2,060 Listeners

600 Listeners

763 Listeners

3,660 Listeners

12,172 Listeners

820 Listeners

6,461 Listeners

112,936 Listeners

4,179 Listeners